Persistent white matter disruption underlies apparent functional normalization in intractable temporal lobe epilepsy: Evidence from multimodal MRI

持续性白质破坏是难治性颞叶癫痫表观功能正常化的潜在机制:来自多模态磁共振成像的证据

阅读:1

Abstract

BACKGROUND: Intractable temporal lobe epilepsy (ITLE) poses ongoing therapeutic challenges due to resistance to antiseizure medications and limited improvements in patient quality of life. Although neuroimaging studies have identified both functional and structural abnormalities in ITLE, their combined analysis and relevance to treatment refractoriness remain unclear. METHODS: We collected longitudinal rs-fMRI and DTI data from 29 patients with ITLE (pre-/post-treatment) and 25 healthy controls and extracted ALFF/ReHo and FA/MD/AD/RD features. Primary inferences were based on conventional group and longitudinal analyses, while exploratory random-forest classification and UMAP visualization were used to compare functional and structural discriminative patterns. RESULTS: Post-treatment functional measures in ITLE patients showed partial normalization toward healthy control levels, whereas white matter abnormalities-especially reduced fractional anisotropy in the Fornix (crus)/Stria terminalis-remained persistent. In exploratory classification analyses, structural features continued to distinguish ITLE from controls after treatment, while functional features more frequently classified post-treatment ITLE cases as healthy, consistent with a structural-functional dissociation. CONCLUSIONS: These findings suggest that persistent white matter microstructural alterations may contribute to treatment resistance in ITLE despite apparent functional normalization. Exploratory machine-learning and low-dimensional visualization offered converging, quantitative support for this dissociation and may help prioritize candidate targets for future validation in larger cohorts.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。